Ipsalazide is a novel sulfasalazine analog designed to release 5-aminosalicylic acid and a non-toxic carrier molecule in the gastrointestinal tract; it is intended for the treatment of colitis, offering the therapeutic benefits of 5-aminosalicylic acid without the side effects associated with sulfasalazine.